Churchill Management Corp Gilead Sciences, Inc. Transaction History

Churchill Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$57.92 - $72.58 $7.25 Million - $9.09 Million	-125,256 Closed	0 $0
Q4 2021 Jan 11, 2022	SELL	$64.88 - $73.64 $276,064 - $313,338	-4,255 Reduced 3.29%	125,256 $9.1 Million
Q3 2021 Oct 13, 2021	BUY	$67.69 - $73.03 $8.77 Million - $9.46 Million	129,511 New	129,511 $9.05 Million
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $12.2 Million - $15.4 Million	-197,024 Closed	0 $0
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $792,267 - $919,968	-10,952 Reduced 5.27%	197,024 $15.2 Million
Q1 2020 Apr 09, 2020	BUY	$62.63 - $80.22 $13 Million - $16.7 Million	207,976 New	207,976 $15.5 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

Stay updated on Churchill Management Corp with notifications on news.